We are live on !
Find out more
Hexavest Portfolio holdings
AUM
$1.64B
Turnover
37.76%
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter Est. Return
+0.89%
1 Year Est. Return
+28.34%
3 Year Est. Return
+75.95%
5 Year Est. Return
+114.8%
10 Year Est. Return
–
AUM
$7.69B
AUM Growth
-$717M
(-8.5%)
Cap. Flow
-$750M
Cap. Flow % of AUM
Cap. Flow %
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
23.45%
Holding
520
New
33
Increased
94
Reduced
159
Closed
37
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$77.8M |
| 2 |
Bank of America
BAC
|
+$61.4M |
| 3 |
Abbott
ABT
|
+$47.7M |
| 4 |
TJX Companies
TJX
|
+$45.3M |
| 5 |
Target
TGT
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$418M |
| 2 |
LyondellBasell Industries
LYB
|
+$62.3M |
| 3 |
American Express
AXP
|
+$51.1M |
| 4 |
Nike
NKE
|
+$48.1M |
| 5 |
Macy's
M
|
+$47.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.54% |
| 2 | Miscellaneous | 16.51% |
| 3 | Consumer Staples | 11.16% |
| 4 | Technology | 10.56% |
| 5 | Financials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $328M | 4.27% |
9,122,716
-723,208
| -7% | -$26.7M |
2013 Q2
16 quarters
|
|
2
Johnson & Johnson
JNJ
$613B
| $225M | 2.93% |
1,704,160
-52,034
| -3% | -$6.64M |
2013 Q2
16 quarters
|
|
3
Pfizer
PFE
$168B
| $222M | 2.89% |
6,975,182
-269,317
| -4% | -$8.49M |
2013 Q2
16 quarters
|
|
4
Verizon
VZ
$185B
| $186M | 2.42% |
4,161,638
+826,932
| +25% | +$38.5M |
2013 Q2
16 quarters
|
|
5
AT&T
T
$160B
| $184M | 2.39% |
6,462,436
-294,237
| -4% | -$8.67M |
2013 Q2
16 quarters
|
|
6
Walmart Inc
WMT
$945B
| $177M | 2.31% |
7,034,583
-331,461
| -4% | -$8.41M |
2013 Q2
16 quarters
|
|
7
Cisco
CSCO
$423B
| $127M | 1.65% |
4,053,314
-116,168
| -3% | -$3.78M |
2013 Q2
16 quarters
|
|
8
Lennar Class A
LEN
$18.1B
| $125M | 1.62% |
2,462,414
-88,635
| -3% | -$4.36M |
2016 Q3
3 quarters
|
|
|
CAA
9
DELISTED
CalAtlantic Group, Inc.
CAA
| $115M | 1.5% |
3,266,163
-105,125
| -3% | -$3.82M |
2016 Q1
5 quarters
|
|
10
Microsoft
MSFT
$3.97T
| $113M | 1.47% |
1,636,417
-46,815
| -3% | -$3.21M |
2013 Q2
16 quarters
|
|
11
Eli Lilly
LLY
$1.11T
| $110M | 1.43% |
1,336,742
-53,079
| -4% | -$4.33M |
2013 Q2
16 quarters
|
|
12
Oracle
ORCL
$395B
| $106M | 1.38% |
2,123,045
-59,101
| -3% | -$2.69M |
2013 Q2
16 quarters
|
|
|
13
VanEck Gold Miners ETF
GDX
$26.5B
| $102M | 1.33% |
4,632,594
-18,364,369
| -80% | -$418M |
2015 Q1
9 quarters
|
|
14
Merck
MRK
$356B
| $95.6M | 1.24% |
1,563,229
-72,487
| -4% | -$4.41M |
2013 Q2
16 quarters
|
|
15
Dollar General
DG
$29.4B
| $91.9M | 1.19% |
1,274,610
-34,739
| -3% | -$2.5M |
2013 Q2
16 quarters
|
|
16
CVS Health
CVS
$118B
| $86.2M | 1.12% |
1,071,737
-53,007
| -5% | -$4.19M |
2014 Q2
12 quarters
|
|
|
17
JPMorgan Chase
JPM
$889B
| $82.7M | 1.07% |
904,516
+901,849
| +33,815% | +$77.8M |
2013 Q2
16 quarters
|
|
18
Travelers Companies
TRV
$80.5B
| $82.5M | 1.07% |
651,698
-11,482
| -2% | -$1.41M |
2014 Q1
13 quarters
|
|
19
Bristol-Myers Squibb
BMY
$121B
| $81.5M | 1.06% |
1,462,991
-61,502
| -4% | -$3.35M |
2013 Q2
16 quarters
|
|
20
Dollar Tree
DLTR
$23.2B
| $81.3M | 1.06% |
1,162,793
-38,863
| -3% | -$3M |
2013 Q2
16 quarters
|
|
21
DELISTED
Walgreens Boots Alliance
WBA
| $80.2M | 1.04% |
1,023,857
-38,577
| -4% | -$3.17M |
2013 Q2
16 quarters
|
|
22
iShares MSCI Emerging Markets ETF
EEM
$29.4B
| $78.2M | 1.02% |
1,890,020
+48,531
| +3% | +$1.98M |
2013 Q2
16 quarters
|
|
23
Pultegroup
PHM
$21.2B
| $76.5M | 0.99% |
3,117,503
-145,719
| -4% | -$3.4M |
2016 Q1
5 quarters
|
|
24
Cardinal Health
CAH
$58.1B
| $75.1M | 0.98% |
963,682
-41,931
| -4% | -$3.16M |
2013 Q2
16 quarters
|
|
25
Procter & Gamble
PG
$368B
| $72.8M | 0.95% |
835,862
-62,649
| -7% | -$5.52M |
2013 Q2
16 quarters
|
|
Similar funds
Hexavest's Q2 2017 Portfolio in Review
As of Q2 2017, Hexavest held 520 positions worth $7.69B, down 8.5% from $8.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Hexavest withdrew a net $750M in Q2 2017, closing 37 positions and reducing 159 holdings. Its most notable exit was Nike, an estimated $48.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Consumer Staples.
Against the trend, Hexavest opened a new position in Bank of America worth $63.9M.
- Hexavest's largest Q2 2017 buy was Bank of America: 2,634,721 shares worth $63.9M.
- Hexavest added most to JPMorgan Chase in Q2 2017, an estimated $77.8M increase.
- Hexavest's biggest Q2 2017 reduction was VanEck Gold Miners ETF, cutting an estimated $418M.
- Hexavest fully exited Nike in Q2 2017, selling an estimated $48.1M.
- Hexavest's ten largest holdings make up 23% of its $7.69B portfolio in Q2 2017.
- Hexavest opened 33 new positions and closed 37 in Q2 2017.
- Hexavest's portfolio value fell 8.5% quarter-over-quarter to $7.69B.
Based on Hexavest's 13F filing for Q2 2017, filed 10 Jul 2017.